The Trump administration released a report on Tuesday that estimated that President Donald Trump’s deals with pharmaceutical companies would save $529 billion over the next ten years.
Affordability has become a top issue for voters as the country moves ever closer to the November midterm elections, which could determine if Republicans will continue to hold the House and Senate majorities. Trump has focused his efforts on cutting deals with drug companies so that the cost of prescription drugs in the country would no longer be substantially higher than other developed nations.
The White House Council of Economic Advisers found that federal and…
Read the full article at BREITBART.COM
